These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26912455)

  • 1. A Case of Pyoderma Gangrenosum in a Patient with Rheumatoid Arthritis Treated with Abatacept.
    Akahoshi-Ikeda M; Yoshizawa S; Motoshita J; Furue M; Takeuchi S
    Acta Derm Venereol; 2016 Aug; 96(6):822-3. PubMed ID: 26912455
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis.
    Vandevyvere K; Luyten FP; Verschueren P; Lories R; Segaert S; Westhovens R
    Clin Rheumatol; 2007 Dec; 26(12):2205-2206. PubMed ID: 17876646
    [No Abstract]   [Full Text] [Related]  

  • 3. Pyoderma gangrenosum in a patient with seronegative rheumatoid arthritis during therapy with adalimumab: toxic effects of adalimumab or failure of adalimumab to prevent the onset of this phenomenon?
    Stichenwirth M; Riedl E; Pehamberger H; Tappeiner G
    Arch Dermatol; 2008 Jun; 144(6):817-8. PubMed ID: 18559788
    [No Abstract]   [Full Text] [Related]  

  • 4. Paradoxical reactions to targeted biological treatments: A way to treat and trigger?
    Brunasso AM; Laimer M; Massone C
    Acta Derm Venereol; 2010 Mar; 90(2):183-5. PubMed ID: 20169304
    [No Abstract]   [Full Text] [Related]  

  • 5. Pyoderma gangrenosum induced by adalimumab in a seropositive rheumatoid arthritis patient: a paradoxical effect of adalimumab?
    Tan Y; Kavaklieva S; Wood F
    Rheumatology (Oxford); 2021 Aug; 60(8):e288-e289. PubMed ID: 33836074
    [No Abstract]   [Full Text] [Related]  

  • 6. Pyoderma gangrenosum possibly triggered by adalimumab.
    Kikuchi N; Hiraiwa T; Ohashi T; Hanami Y; Satoh M; Takenoshita H; Yamamoto T
    Eur J Dermatol; 2012; 22(6):804-5. PubMed ID: 23107608
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of infliximab in a patient with pyoderma gangrenosum and rheumatoid arthritis.
    Tada M; Nakanishi T; Hirata C; Okano T; Sugioka Y; Wakitani S; Nakamura H; Koike T
    Mod Rheumatol; 2010 Dec; 20(6):598-601. PubMed ID: 20680379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First report of membranous nephropathy and systemic lupus erythematosus associated with abatacept in rheumatoid arthritis.
    Asami Y; Ishiguro H; Ueda A; Nakajima H
    Clin Exp Rheumatol; 2016; 34(6):1122. PubMed ID: 27462998
    [No Abstract]   [Full Text] [Related]  

  • 9. A Case of Disseminated Histoplasmosis in a Patient with Rheumatoid Arthritis on Abatacept.
    Jain N; Doyon JB; Lazarus JE; Schaefer IM; Johncilla ME; Agoston AT; Dalal AK; Velásquez GE
    J Gen Intern Med; 2018 May; 33(5):769-772. PubMed ID: 29532302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosacea and abatacept: the first report of a possible correlation.
    Lo Schiavo A; Tirri R; Peccerillo F; Abbondanza C; Russo B; Caccavale S
    G Ital Dermatol Venereol; 2016 Feb; 151(1):123. PubMed ID: 26924033
    [No Abstract]   [Full Text] [Related]  

  • 11. Psoriatic skin lesions induced by abatacept: Case report and review of the published work.
    Ueda-Hayakawa I; Nguyen Thi Hong C; Ueki Y; Kambe N; Okamoto H
    J Dermatol; 2017 Jul; 44(7):845-846. PubMed ID: 27542572
    [No Abstract]   [Full Text] [Related]  

  • 12. Atopic Dermatitis Flare during Abatacept Therapy.
    Stinco G; Bergamo S; Frattasio A; di Meo N; Trevisan G
    J Cutan Med Surg; 2014 Nov; 18(6):369-70. PubMed ID: 25348756
    [No Abstract]   [Full Text] [Related]  

  • 13. Kaposi's sarcoma after T-cell costimulation blockade with abatacept in rheumatoid arthritis: a case report.
    Olivo D; Grembiale RD; Tallarigo F; Russo E; De Sarro G; Ursini F
    J Clin Pharm Ther; 2017 Jun; 42(3):367-369. PubMed ID: 28262965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous cyclophosphamide pulses in the treatment of pyoderma gangrenosum associated with rheumatoid arthritis.
    Nordstrom D
    J Rheumatol; 1995 May; 22(5):1000-1. PubMed ID: 8587061
    [No Abstract]   [Full Text] [Related]  

  • 15. Reactivation of occult hepatitis B virus infection under treatment with abatacept: a case report.
    Talotta R; Atzeni F; Sarzi Puttini P
    BMC Pharmacol Toxicol; 2016 Apr; 17():17. PubMed ID: 27098382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retention and clinical response to abatacept in patients with rheumatoid arthritis: an Italian perspective.
    Galeazzi M; Alten R; Chartier M; Elbez Y; Fusaro E; Le Bars M; Lorenz HM; Pagano Mariano G; Muratore M; Nüßlein HG; Patanè G
    Clin Exp Rheumatol; 2018; 36(5):935-936. PubMed ID: 29600933
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of tocilizumab in a patient with pyoderma gangrenosum and rheumatoid arthritis.
    Lee WS; Choi YJ; Yoo WH
    J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):e75-e77. PubMed ID: 27325564
    [No Abstract]   [Full Text] [Related]  

  • 18. Cryptococcal Meningitis in a Patient With Rheumatoid Arthritis Treated With Abatacept.
    Mino M; Yamasaki M; Nabeshima S; Fujimoto Y; Kurushima H; Taniwaki M; Matsumoto N; Kawamoto K; Izumi Y; Otohara M; Hattori N
    J Clin Rheumatol; 2021 Dec; 27(8S):S701-S702. PubMed ID: 33065627
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid development of severe acute respiratory distress syndrome after abatacept treatment in a patient with rheumatoid arthritis.
    Gower J; Labarca G; Enos D; Nova-Lamperti E
    BMJ Case Rep; 2020 Apr; 13(4):. PubMed ID: 32265206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyoderma gangrenosum in a patient with rheumatoid arthritis responding to treatment with cyclosporin A.
    Hughes JR; Smith E; Higgins EM; Berry H; du Vivier AW
    Br J Rheumatol; 1994 Jul; 33(7):680-1. PubMed ID: 8019800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.